Yae-Jean Kim
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Adoptive Transfer of pp65-specific T Cells for the Treatment of Refractory Cytomegalovirus (CMV) Infection (NCT02346617) | Yae-Jean Kim | 2022-01-01 |
Track Yae-Jean Kim automatically
Every clearance here is in the API, with alerts when new ones post.